Dhampur Bio Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 2, 2025, 8:24 pm

Market Cap	441 Cr.
Current Price	67.7
High / Low	164/57.3
Stock P/E	39.8
Book Value	146
Dividend Yield	3.69 %
ROCE	5.02 %
ROE	3.67 %
Face Value	10.0
PEG Ratio	-0.71

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Dhampur Bio Organics Ltd

Competitors of Dhampur Bio Organics Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gayatri Sugars Ltd	71.0 Cr.	9.55	26.5/8.06		19.1	0.00 %	93.2 %	%	10.0
Dhampure Speciality Sugars Ltd	84.0 Cr.	101	142/78.0	50.6	35.6	0.00 %	3.15 %	3.78 %	10.0
Dhampur Bio Organics Ltd	441 Cr.	67.7	164/57.3	39.8	146	3.69 %	5.02 %	3.67 %	10.0
DCM Shriram Industries Ltd	1,545 Cr.	178	242/142	13.3	100	1.13 %	16.1 %	14.9 %	2.00
Davangere Sugar Company Ltd	361 Cr.	3.85	10.9/3.70	26.7	3.64	0.00 %	6.86 %	3.75 %	1.00
Industry Average	1,911.41 Cr	285.16		21.44	224.49	0.81%	12.98%	13.21%	6.37

All Competitor Stocks of Dhampur Bio Organics Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	347.65	505.86	495.70	515.07	593.54	803.23	583.29	538.18	280.02	462.95	466.99	465.97	464.31
Expenses	312.16	404.15	463.80	492.70	559.24	687.04	542.75	519.02	284.45	381.79	434.05	475.71	448.38
Operating Profit	35.49	101.71	31.90	22.37	34.30	116.19	40.54	19.16	-4.43	81.16	32.94	-9.74	15.93
OPM %	10.21%	20.11%	6.44%	4.34%	5.78%	14.47%	6.95%	3.56%	-1.58%	17.53%	7.05%	-2.09%	3.43%
Other Income	0.36	4.34	2.51	6.19	0.98	1.74	2.35	0.62	15.86	5.04	0.78	1.39	-1.33
Interest	2.90	10.33	14.33	9.12	4.87	12.53	13.32	8.81	5.65	17.55	21.11	15.77	10.07
Depreciation	8.34	9.92	8.45	8.74	10.22	13.11	11.08	10.49	13.62	14.29	11.89	11.32	14.67
Profit before tax	24.61	85.80	11.63	10.70	20.19	92.29	18.49	0.48	-7.84	54.36	0.72	-35.44	-10.14
Tax %	27.14%	17.30%	29.06%	27.94%	25.80%	13.10%	31.53%	87.50%	-28.06%	27.50%	83.33%	-34.06%	-32.35%
Net Profit	17.92	70.96	8.25	7.71	14.98	80.20	12.66	0.06	-5.64	39.41	0.12	-23.37	-6.86
EPS in Rs			1.24	1.16	2.26	12.08	1.91	0.01	-0.85	5.94	0.02	-3.52	-1.03

Last Updated: February 28, 2025, 12:09 pm

Below is a detailed analysis of the quarterly data for Dhampur Bio Organics Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹464.31 Cr.. The value appears to be declining and may need further review. It has decreased from 465.97 Cr. (Sep 2024) to ₹464.31 Cr., marking a decrease of 1.66 Cr..
For Expenses, as of Dec 2024, the value is ₹448.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 475.71 Cr. (Sep 2024) to ₹448.38 Cr., marking a decrease of 27.33 Cr..
For Operating Profit, as of Dec 2024, the value is ₹15.93 Cr.. The value appears strong and on an upward trend. It has increased from -9.74 Cr. (Sep 2024) to ₹15.93 Cr., marking an increase of 25.67 Cr..
For OPM %, as of Dec 2024, the value is 3.43%. The value appears strong and on an upward trend. It has increased from -2.09% (Sep 2024) to 3.43%, marking an increase of 5.52%.
For Other Income, as of Dec 2024, the value is ₹-1.33 Cr.. The value appears to be declining and may need further review. It has decreased from 1.39 Cr. (Sep 2024) to ₹-1.33 Cr., marking a decrease of 2.72 Cr..
For Interest, as of Dec 2024, the value is ₹10.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.77 Cr. (Sep 2024) to ₹10.07 Cr., marking a decrease of 5.70 Cr..
For Depreciation, as of Dec 2024, the value is ₹14.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.32 Cr. (Sep 2024) to ₹14.67 Cr., marking an increase of 3.35 Cr..
For Profit before tax, as of Dec 2024, the value is ₹-10.14 Cr.. The value appears strong and on an upward trend. It has increased from -35.44 Cr. (Sep 2024) to ₹-10.14 Cr., marking an increase of 25.30 Cr..
For Tax %, as of Dec 2024, the value is -32.35%. The value appears to be increasing, which may not be favorable. It has increased from -34.06% (Sep 2024) to -32.35%, marking an increase of 1.71%.
For Net Profit, as of Dec 2024, the value is ₹-6.86 Cr.. The value appears strong and on an upward trend. It has increased from -23.37 Cr. (Sep 2024) to ₹-6.86 Cr., marking an increase of 16.51 Cr..
For EPS in Rs, as of Dec 2024, the value is -1.03. The value appears strong and on an upward trend. It has increased from -3.52 (Sep 2024) to -1.03, marking an increase of 2.49.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 4:40 pm

Metric	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	0	1,564	2,408	1,864	1,860
Expenses	0	1,381	2,203	1,724	1,740
Operating Profit	-0	183	205	140	120
OPM %		12%	8%	8%	6%
Other Income	0	8	11	20	6
Interest	0	30	41	45	64
Depreciation	0	31	41	49	52
Profit before tax	-0	129	135	65	10
Tax %	0%	21%	18%	29%
Net Profit	-0	102	111	46	9
EPS in Rs			16.74	7.00	1.41
Dividend Payout %	0%	0%	21%	36%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2022-2023	2023-2024
YoY Net Profit Growth (%)	8.82%	-58.56%
Change in YoY Net Profit Growth (%)	0.00%	-67.38%

Dhampur Bio Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 2 years from 2022-2023 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-16%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	1443%
TTM:	-87%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	-48%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	9%
Last Year:	4%

Last Updated: Unknown

Balance Sheet

Last Updated: March 14, 2025, 1:55 pm

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	66	66	66	66	66
Reserves	709	812	922	945	905
Borrowings	403	835	810	1,057	573
Other Liabilities	373	287	278	244	125
Total Liabilities	1,551	2,000	2,077	2,313	1,669
Fixed Assets	631	690	909	1,036	1,018
CWIP	7	78	36	13	94
Investments	0	0	0	0	0
Other Assets	913	1,232	1,132	1,263	557
Total Assets	1,551	2,000	2,077	2,313	1,669

Below is a detailed analysis of the balance sheet data for Dhampur Bio Organics Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹66.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 66.00 Cr..
For Reserves, as of Sep 2024, the value is ₹905.00 Cr.. The value appears to be declining and may need further review. It has decreased from 945.00 Cr. (Mar 2024) to ₹905.00 Cr., marking a decrease of 40.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹573.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,057.00 Cr. (Mar 2024) to ₹573.00 Cr., marking a decrease of 484.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹125.00 Cr.. The value appears to be improving (decreasing). It has decreased from 244.00 Cr. (Mar 2024) to ₹125.00 Cr., marking a decrease of 119.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹1,669.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,313.00 Cr. (Mar 2024) to ₹1,669.00 Cr., marking a decrease of 644.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹1,018.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,036.00 Cr. (Mar 2024) to ₹1,018.00 Cr., marking a decrease of 18.00 Cr..
For CWIP, as of Sep 2024, the value is ₹94.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to ₹94.00 Cr., marking an increase of 81.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹557.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,263.00 Cr. (Mar 2024) to ₹557.00 Cr., marking a decrease of 706.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹1,669.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,313.00 Cr. (Mar 2024) to ₹1,669.00 Cr., marking a decrease of 644.00 Cr..

Notably, the Reserves (₹905.00 Cr.) exceed the Borrowings (573.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-0	-246	368	-101
Cash from Investing Activity +	0	-124	-209	-166
Cash from Financing Activity +	0	393	-78	170
Net Cash Flow	0	23	81	-98

Free Cash Flow

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-403.00	-652.00	-605.00	139.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2022	Mar 2023	Mar 2024
Debtor Days	25	23	17
Inventory Days	341	163	288
Days Payable	54	33	37
Cash Conversion Cycle	312	154	269
Working Capital Days	225	121	204
ROCE %	11%	10%	5%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	May 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	49.08%	49.09%	50.22%	50.22%	50.45%	50.45%	50.64%	50.79%	50.79%	50.79%	50.79%
FIIs	8.55%	7.37%	6.63%	5.34%	4.81%	4.83%	3.42%	1.95%	1.26%	0.83%	0.66%
DIIs	0.49%	0.58%	0.49%	0.47%	0.45%	0.45%	0.45%	0.45%	0.45%	1.35%	0.45%
Public	41.88%	42.96%	42.67%	43.98%	44.30%	44.26%	45.51%	46.82%	47.51%	47.04%	48.10%
No. of Shareholders	62,082	60,352	55,770	54,704	54,376	53,825	55,746	54,291	52,118	50,563	50,263

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	7.00	16.74	15.35	0.00
Diluted EPS (Rs.)	7.00	16.74	15.35	0.00
Cash EPS (Rs.)	14.46	22.84	20.06	0.00
Book Value[Excl.RevalReserv]/Share (Rs.)	152.35	148.93	132.16	116.73
Book Value[Incl.RevalReserv]/Share (Rs.)	152.35	148.93	132.16	116.73
Revenue From Operations / Share (Rs.)	280.83	362.63	232.10	0.00
PBDIT / Share (Rs.)	24.15	32.56	28.68	0.00
PBIT / Share (Rs.)	16.69	26.45	23.96	0.00
PBT / Share (Rs.)	9.86	20.30	19.43	0.00
Net Profit / Share (Rs.)	7.00	16.73	15.35	0.00
NP After MI And SOA / Share (Rs.)	7.00	16.73	15.35	0.00
PBDIT Margin (%)	8.59	8.97	12.35	0.00
PBIT Margin (%)	5.94	7.29	10.32	0.00
PBT Margin (%)	3.51	5.59	8.36	0.00
Net Profit Margin (%)	2.49	4.61	6.61	0.00
NP After MI And SOA Margin (%)	2.49	4.61	6.61	0.00
Return on Networth / Equity (%)	4.59	11.23	11.61	0.00
Return on Capital Employeed (%)	8.78	14.41	15.23	0.00
Return On Assets (%)	2.01	5.34	5.09	0.00
Long Term Debt / Equity (X)	0.17	0.17	0.11	0.12
Total Debt / Equity (X)	1.03	0.81	0.93	0.50
Asset Turnover Ratio (%)	0.84	1.18	0.86	0.00
Current Ratio (X)	1.19	1.31	1.28	1.46
Quick Ratio (X)	0.16	0.35	0.17	0.29
Inventory Turnover Ratio (X)	1.69	1.69	1.62	0.00
Dividend Payout Ratio (NP) (%)	49.96	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	24.20	0.00	0.00	0.00
Earning Retention Ratio (%)	50.04	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	75.80	0.00	0.00	0.00
Interest Coverage Ratio (X)	3.54	5.29	6.32	0.00
Interest Coverage Ratio (Post Tax) (X)	2.03	3.72	4.38	0.00
Enterprise Value (Cr.)	1776.49	1647.22	0.00	0.00
EV / Net Operating Revenue (X)	0.95	0.68	0.00	0.00
EV / EBITDA (X)	11.08	7.62	0.00	0.00
MarketCap / Net Operating Revenue (X)	0.40	0.39	0.00	0.00
Retention Ratios (%)	50.03	0.00	0.00	0.00
Price / BV (X)	0.75	0.96	0.00	0.00
Price / Net Operating Revenue (X)	0.40	0.39	0.00	0.00
EarningsYield	0.06	0.11	0.00	0.00

After reviewing the key financial ratios for Dhampur Bio Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 7.00. This value is within the healthy range. It has decreased from 16.74 (Mar 23) to 7.00, marking a decrease of 9.74.
For Diluted EPS (Rs.), as of Mar 24, the value is 7.00. This value is within the healthy range. It has decreased from 16.74 (Mar 23) to 7.00, marking a decrease of 9.74.
For Cash EPS (Rs.), as of Mar 24, the value is 14.46. This value is within the healthy range. It has decreased from 22.84 (Mar 23) to 14.46, marking a decrease of 8.38.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 152.35. It has increased from 148.93 (Mar 23) to 152.35, marking an increase of 3.42.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 152.35. It has increased from 148.93 (Mar 23) to 152.35, marking an increase of 3.42.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 280.83. It has decreased from 362.63 (Mar 23) to 280.83, marking a decrease of 81.80.
For PBDIT / Share (Rs.), as of Mar 24, the value is 24.15. This value is within the healthy range. It has decreased from 32.56 (Mar 23) to 24.15, marking a decrease of 8.41.
For PBIT / Share (Rs.), as of Mar 24, the value is 16.69. This value is within the healthy range. It has decreased from 26.45 (Mar 23) to 16.69, marking a decrease of 9.76.
For PBT / Share (Rs.), as of Mar 24, the value is 9.86. This value is within the healthy range. It has decreased from 20.30 (Mar 23) to 9.86, marking a decrease of 10.44.
For Net Profit / Share (Rs.), as of Mar 24, the value is 7.00. This value is within the healthy range. It has decreased from 16.73 (Mar 23) to 7.00, marking a decrease of 9.73.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 7.00. This value is within the healthy range. It has decreased from 16.73 (Mar 23) to 7.00, marking a decrease of 9.73.
For PBDIT Margin (%), as of Mar 24, the value is 8.59. This value is below the healthy minimum of 10. It has decreased from 8.97 (Mar 23) to 8.59, marking a decrease of 0.38.
For PBIT Margin (%), as of Mar 24, the value is 5.94. This value is below the healthy minimum of 10. It has decreased from 7.29 (Mar 23) to 5.94, marking a decrease of 1.35.
For PBT Margin (%), as of Mar 24, the value is 3.51. This value is below the healthy minimum of 10. It has decreased from 5.59 (Mar 23) to 3.51, marking a decrease of 2.08.
For Net Profit Margin (%), as of Mar 24, the value is 2.49. This value is below the healthy minimum of 5. It has decreased from 4.61 (Mar 23) to 2.49, marking a decrease of 2.12.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 2.49. This value is below the healthy minimum of 8. It has decreased from 4.61 (Mar 23) to 2.49, marking a decrease of 2.12.
For Return on Networth / Equity (%), as of Mar 24, the value is 4.59. This value is below the healthy minimum of 15. It has decreased from 11.23 (Mar 23) to 4.59, marking a decrease of 6.64.
For Return on Capital Employeed (%), as of Mar 24, the value is 8.78. This value is below the healthy minimum of 10. It has decreased from 14.41 (Mar 23) to 8.78, marking a decrease of 5.63.
For Return On Assets (%), as of Mar 24, the value is 2.01. This value is below the healthy minimum of 5. It has decreased from 5.34 (Mar 23) to 2.01, marking a decrease of 3.33.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.17. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.17.
For Total Debt / Equity (X), as of Mar 24, the value is 1.03. This value exceeds the healthy maximum of 1. It has increased from 0.81 (Mar 23) to 1.03, marking an increase of 0.22.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.84. It has decreased from 1.18 (Mar 23) to 0.84, marking a decrease of 0.34.
For Current Ratio (X), as of Mar 24, the value is 1.19. This value is below the healthy minimum of 1.5. It has decreased from 1.31 (Mar 23) to 1.19, marking a decrease of 0.12.
For Quick Ratio (X), as of Mar 24, the value is 0.16. This value is below the healthy minimum of 1. It has decreased from 0.35 (Mar 23) to 0.16, marking a decrease of 0.19.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.69. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 23) which recorded 1.69.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 49.96. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 49.96, marking an increase of 49.96.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 24.20. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 24.20, marking an increase of 24.20.
For Earning Retention Ratio (%), as of Mar 24, the value is 50.04. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 50.04, marking an increase of 50.04.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 75.80. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 75.80, marking an increase of 75.80.
For Interest Coverage Ratio (X), as of Mar 24, the value is 3.54. This value is within the healthy range. It has decreased from 5.29 (Mar 23) to 3.54, marking a decrease of 1.75.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.03. This value is below the healthy minimum of 3. It has decreased from 3.72 (Mar 23) to 2.03, marking a decrease of 1.69.
For Enterprise Value (Cr.), as of Mar 24, the value is 1,776.49. It has increased from 1,647.22 (Mar 23) to 1,776.49, marking an increase of 129.27.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.68 (Mar 23) to 0.95, marking an increase of 0.27.
For EV / EBITDA (X), as of Mar 24, the value is 11.08. This value is within the healthy range. It has increased from 7.62 (Mar 23) to 11.08, marking an increase of 3.46.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.39 (Mar 23) to 0.40, marking an increase of 0.01.
For Retention Ratios (%), as of Mar 24, the value is 50.03. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 50.03, marking an increase of 50.03.
For Price / BV (X), as of Mar 24, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 23) to 0.75, marking a decrease of 0.21.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.39 (Mar 23) to 0.40, marking an increase of 0.01.
For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 23) to 0.06, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Dhampur Bio Organics Ltd as of April 2, 2025 is: 176.90

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 2, 2025, Dhampur Bio Organics Ltd is Undervalued by 161.30% compared to the current share price 67.70

Intrinsic Value of Dhampur Bio Organics Ltd as of April 2, 2025 is: 77.54

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 2, 2025, Dhampur Bio Organics Ltd is Undervalued by 14.53% compared to the current share price 67.70

Last 5 Year EPS CAGR: -56.16%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (858.60 cr) compared to borrowings (735.60 cr), indicating strong financial stability. The company has shown consistent growth in sales (1.00 cr) and profit (67.80 cr) over the years.	The stock has a low average ROCE of 6.50%, which may not be favorable. The stock has a high average Working Capital Days of 137.50, which may not be favorable. The stock has a high average Cash Conversion Cycle of 183.75, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dhampur Bio Organics Ltd:
1. Net Profit Margin: 2.49%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 8.78% (Industry Average ROCE: 12.98%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 4.59% (Industry Average ROE: 11.89%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.03
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.16
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 39.8 (Industry average Stock P/E: 15.72)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 1.03
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Dhampur Bio Organics Ltd. is a Public Limited Listed company incorporated on 26/10/2022 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L15100UP2020PLC136939 and registration number is 136939. Currently Company is involved in the business activities of Manufacture of sugar. Company's Total Operating Revenue is Rs. 1831.18 Cr. and Equity Capital is Rs. 66.39 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Sugar	Sugar Mill Compound, Village & Post - Asmoli, Sambhal Dist. Uttar Pradesh 244304	investors@dhampur.com http://www.dhampur.com

Management
Name	Position Held
Mr. Vijay Kumar Goel	Chairman
Mr. Ashwani Kumar Gupta	Vice Chairman
Mr. Gautam Goel	Managing Director
Mr. Sandeep Kumar Sharma	Whole Time Director
Mrs. Bindu Vashist Goel	Non Executive Director
Mrs. Ruchika Amrish Mehra Kothari	Independent Director
Mr. Vishal Saluja	Independent Director
Mr. Samir Thukral	Independent Director
Mr. Kishor Shah	Independent Director

FAQ

What is the intrinsic value of Dhampur Bio Organics Ltd?

Dhampur Bio Organics Ltd's intrinsic value (as of 02 April 2025) is ₹176.90 — 161.30% higher the current market price of ₹67.70, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 441 Cr. market cap, FY2025-2026 high/low of ₹164/57.3, reserves of 905 Cr, and liabilities of 1,669 Cr.

What is the Market Cap of Dhampur Bio Organics Ltd?

The Market Cap of Dhampur Bio Organics Ltd is 441 Cr..

What is the current Stock Price of Dhampur Bio Organics Ltd as on 02 April 2025?

The current stock price of Dhampur Bio Organics Ltd as on 02 April 2025 is 67.7.

What is the High / Low of Dhampur Bio Organics Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Dhampur Bio Organics Ltd stocks is ₹164/57.3.

What is the Stock P/E of Dhampur Bio Organics Ltd?

The Stock P/E of Dhampur Bio Organics Ltd is 39.8.

What is the Book Value of Dhampur Bio Organics Ltd?

The Book Value of Dhampur Bio Organics Ltd is 146.

What is the Dividend Yield of Dhampur Bio Organics Ltd?

The Dividend Yield of Dhampur Bio Organics Ltd is 3.69 %.

What is the ROCE of Dhampur Bio Organics Ltd?

The ROCE of Dhampur Bio Organics Ltd is 5.02 %.

What is the ROE of Dhampur Bio Organics Ltd?

The ROE of Dhampur Bio Organics Ltd is 3.67 %.

What is the Face Value of Dhampur Bio Organics Ltd?

The Face Value of Dhampur Bio Organics Ltd is 10.0.